Ikarian Healthcare Master Fund, L.P. is 10% Owner at Tracon Pharmaceuticals, Inc. (TCON). They have made 1 open-market trade across 1 company since 2020, most recently 2020-09-11.
CIK 0001824870
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.1M since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TCON | 2,004,933 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2020-09-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TCON | BUY | 2020-09-04 | 2020-09-15 | $3.28 | $1.1M | +4.1% | +16.2% | +76.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.